U0126 | MEK選擇性非競爭型抑制劑 | 貨號1668-5 A MEK inhibitor Abcam操作手冊 (Abcam ab120241)
Alternate Name/Synonyms: 1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto) butadiene
MAP kinase kinase(MEK)選擇性非競爭型抑制劑. Potent and selective non-competitive inhibitor of MAP kinase kinase(MEK). Inhibits MEK-1 and MEK-2 (IC₅₀ values of 0.07 and 0.06 µM respectively) with little or no effect on the activities of PKC, Abl, Raf, MEKK, ERK, JNK, MKK-3, MKK-4/SEK, MKK-6, Cdk2 or Cdk4. 分子型式C₁₈H₁₆N₆S₂ | 分子量Molecular Weight: 380.48 | 純度Purity: ≥98% by HPLC | Solubility: DMSO (>10 mg/ml)
| Catalog # | Product Name+ | Size |
| 1594-100 | BAY 43-9006 | 100 mg |
| 1594-25 | BAY 43-9006 | 25 mg |
| 1954-5 | Doramapimod | 5 mg |
| 1954-25 | Doramapimod | 25 mg |
| 1783-5 | EZSolution™ PD 98059 | 5 mg |
| 1871-1 | EZSolution™ PD184352 | 1 mg |
| 1786-1 | EZSolution™ SB 203580 | 1 mg |
| 2729-5 | JNK-IN-8 | 5 mg |
| 2729-25 | JNK-IN-8 | 25 mg |
| 7011-50 | L-JNK Peptide Inhibitor I | 50 µl |
| K862-7 | PathwayReady™ MAP Kinase Signaling Inhibitor Panel | 7 inhibitors |
| 1666-5 | PD 98059 | 5 mg |
| 1643-2 | PD-0325901 | 2 mg |
| 1643-5 | PD-0325901 | 5 mg |
| 1643-25 | PD-0325901 | 25 mg |
| 1585-25 | PD184352 | 25 mg |
| 1585-5 | PD184352 | 5 mg |
| 1585-1 | PD184352 | 1 mg |
| 1712-1 | SB 203580 | 1 mg |
| 1712-5 | SB 203580 | 5 mg |
| 1669-5 | SP600125 | 5 mg |
| 1668-5 | U0126 | 5 mg |
| 1598-1 | VX-702 | 1 mg |
| 1598-5 | VX-702 | 5 mg |
文章標籤
全站熱搜
留言列表
代理品牌 (20)
{{ article.title }}
